Top Social Impact Companies With Best Stability & Growth (4,262)

Strong Market Position & Advantage: Public materials consistently cite more than 1,300 organizations on the platform, including global pharmas like Merck, Moderna, and Sanofi. This breadth and logo depth indicate entrenched presence across modern biotech R&D.

Innovation-Driven Growth: The company continues launching new capabilities (e.g., Benchling Models, Biologics updates, Validated Cloud) and reports broad uptake of Benchling AI after GA, suggesting expanding use cases across its base. Ecosystem moves like one‑click ordering integrations point to product‑led expansion.

Strong Revenue Growth: Independent estimates describe ARR above $200M in 2024 and increasing year over year. This supports a view of continued top‑line expansion despite a tougher market context.

Strong Revenue Growth: Public listings like Deloitte’s Technology Fast 500 across multiple years and company disclosures indicating continued momentum into 2024–2026 point to sustained top-line expansion.

Market Expansion: Reports of a London office opening, larger Austin headquarters, and rising global customer reach signal growing geographic footprint and scale.

Product Line Growth: Recent AI-driven launches, the Pyrra acquisition, and partnerships with Riskonnect and Healix broaden the platform into social intelligence and end-to-end travel risk management.

Strong Revenue Growth: Company disclosures indicate Hinge’s direct revenue rose steadily through late 2025 and continued to increase in early 2026. Portfolio commentary links recent outperformance in part to Hinge’s sustained momentum.

Market Expansion: Hinge broadened its footprint across Europe and into Latin America and India, achieving top download ranks in targeted European countries and quickly reaching high positions in Mexico and Brazil. Management outlines continued international rollouts with organic traction preceding full marketing.

Innovation-Driven Growth: The app introduced verification and conversation tools (e.g., Face Check, Convo Starters) that are reported to improve outcomes and safety while supporting monetization. Its “intentional dating” positioning aligns product features with higher‑intent engagement.

Investor Backing & Capital Strength: Successive up-rounds (Series C in 2023 and Series D in 2024) with a marked valuation step-up indicate strong investor conviction and ample capital for expansion. Feedback suggests this funding underpins continued product investment and nationwide scaling.

Market Expansion: The platform reports activity in all 50 states and D.C., rising provider and patient counts, and expansion into Medicare Advantage and Medicaid. Help-center updates and company materials highlight broader coverage and multi‑state credentialing enabling nationwide reach.

Strategic Partnerships: Participation with major insurers (e.g., Aetna, select BCBS plans, Cigna/Evernorth, UnitedHealthcare/Optum) and support from partners like BCBS Massachusetts signal strong payer alignment. These relationships appear to facilitate national scale and access across plan types.

Innovation-Driven Growth: Recent launches of VelocityAI, the Vēlo assistant, and an AI “Hands & Wrists” assessment indicate active R&D and product expansion aimed at upsell and new logo wins. Ongoing product investment supports cross‑sell opportunities and differentiation in core EHS domains.

Strong Market Position & Advantage: Placement as a Verdantix Green Quadrant Leader and a #6 global rank in G2’s 2026 Best Software Awards signal recognized competitive standing and broad customer traction. Third‑party accolades point to perceived leadership and visibility in the market.

Investor Backing & Capital Strength: Long‑term ownership by CVC Growth and a significant minority stake from Partners Group provide sponsor support often used to fund organic growth and M&A. The appointment of a Chief Revenue Officer “to accelerate growth” reflects go‑to‑market scaling supported by governance.

Investor Backing & Capital Strength: Recent announcements cite a $450M raise in February 2026 to fund up to 10,000 additional U.S. restaurants, with multiple trackers reflecting the facility. Statements also note over $600M deployed to date, indicating a larger funding base.

Strong Revenue Growth: Third-party trackers report 2025 revenue around $350M and company materials highlight multi-year increases in gross order volume. These signals reinforce a larger operating scale than prior years.

Market Expansion: Disclosures reference thousands of partner restaurants, 4M+ users, and broader distribution through channels like Costco. Plans to add 10,000 restaurants and ongoing hiring point to accelerating reach.

Strong Hiring & Retention: Active, multi‑team openings across Client Experience, Engineering, Product, Operations, and leadership indicate ongoing headcount expansion. Feedback suggests broad hiring aligns with an expansionary near‑term trajectory.

Investor Backing & Capital Strength: Multiple funding rounds from prominent investors are cited, supporting scale‑up and new initiatives. Feedback suggests this capital base underpins continued hiring and vertical expansion.

Market Expansion: Nationwide coverage across disability, workers’ compensation, and VA benefits, along with state‑specific intake pages, points to broad geographic and service reach. Expansion into additional benefit categories indicates a widening addressable market.

Market Expansion: Public materials indicate the network has expanded to 6,000+ research sites across 50+ countries and 25+ sponsors, up from 5,500+ sites cited in late 2025. This footprint growth signals broader geographic reach and increasing demand-side participation.

Strategic Partnerships: Announced partnerships such as the September 2025 RealTime eClinical data-integration open access to 50+ large site networks (2,000+ sites) and enrich marketplace data. Additional integrations (e.g., eClinPro in 2026) reinforce distribution and embed the platform more deeply in site workflows.

Innovation-Driven Growth: The company launched AI-enabled pre-screening, AI site selection, and EHR integration in 2025–2026 to improve patient identification and sponsor decision-making. These capabilities can increase conversion and make the platform more attractive to both sites and sponsors.

Strong Revenue Growth: Reported record revenue for full-year 2025 and a record first quarter in 2026, with management maintaining full-year guidance. Receivables also grew year over year, reinforcing momentum.

Profitability: Full-year 2025 delivered record adjusted net income and GAAP profitability, indicating sustained earnings strength. Management’s 2026 outlook anticipates further adjusted net income growth.

Market Expansion: A planned acquisition of BNCCORP/BNC National Bank is intended to broaden products and geography while reducing funding costs. Simplifying the capital structure to a traditional C‑corp further supports scalability.

Investor Backing & Capital Strength: GV led a $28.1M round in February 2023 to scale firsthand’s Medicaid-focused SMI model and multi‑state operations. This capital provides runway supporting ongoing activity despite subsequent turbulence.

Market Expansion: Operations span multiple states (e.g., Florida, Ohio, Michigan, Virginia, Washington) with active postings in 2026, indicating selective growth and continuation in targeted markets. Company materials and social updates point to stabilization and focused re‑entry after 2025 cuts.

Strategic Partnerships: The model centers on payer partnerships in Medicaid, and firsthand is a contracted provider with Molina, aligning offerings with managed‑care needs. Such plan relationships underpin access to attributed lives and contract‑driven revenue.

Market Expansion: Playground markets itself as serving 5,000+ child‑care programs and appears in current startup ecosystem materials (e.g., the 2026 GSV Cup Look Book), indicating broader visibility and reach. Recently published customer stories on the site suggest ongoing adoption across providers.

Innovation-Driven Growth: The public changelog documents regular releases through April 20, 2026, including a new dialer and AI‑suggested tasks, consistent with an actively maintained platform. References to AI‑enabled capabilities reinforce an emphasis on product innovation.

Strong Hiring & Retention: The company’s careers page lists open roles with a structured recruiting process, and Built In NYC’s profile notes continued hiring alongside revenue growth. Active recruiting supports the narrative of a scaling organization.

Investor Backing & Capital Strength: Recent Series B financing led by a tier‑one investor and total funding of $50M indicate a strong capital position to support scaling. Announced plans link this capital to product and market expansion through 2025–2026.

Market Expansion: Public materials describe serving large patient volumes across dozens of states and adding specialties beyond behavioral health into areas like home health, long‑term care, and substance use care. Partnerships and broader specialty positioning suggest widening distribution and reach.

Strong Hiring & Retention: Active job postings into 2026 and multiple open roles point to ongoing team expansion aligned with go‑to‑market and operations scale‑up. Company and aggregator pages consistently show a growing employee band.

Market Expansion: The Captionmax and National Captioning Canada acquisition added live services and Canadian reach. A 2025 rebrand positioned the company toward global video localization and accessibility, indicating a broader go‑to‑market.

Product Line Growth: New offerings include a global linguist marketplace and AI‑enabled localization/EAA compliance solutions in 2025, plus an AI dubbing solution for YouTube creators in April 2026. These launches show expansion into adjacent workflows beyond core captioning.

Investor Backing & Capital Strength: Riverside Partners’ 2019 investment provides institutional sponsorship typical of scale‑up platforms. This backing supported organic investment and acquisitions such as Captionmax.

Profitability: 2024 net income increased versus 2023, supported by mortgage banking income that nearly doubled year over year. The company also reports improved efficiency and earnings despite margin pressure.

Market Expansion: The bank announced three full‑service branches for 2026 and added a Boston‑based retail banking team, signaling a push to grow core deposits and presence. New locations are being promoted, with the Seaport branch live and Falmouth listed as coming soon with community events.

Product Line Growth: New and expanded lines such as a national SBA lending division, securities‑based lending, insurance, and 1031 exchange services broaden revenue sources. Partnerships like Blend and DepositLink support scaling and distribution.

Investor Backing & Capital Strength: Funding announcements show Marble Health raised a $15.5M Series A in October 2025 led by Costanoa with participation from Town Hall Ventures and Khosla Ventures, signaling strong investor support. Company and investor communications indicate this capital is earmarked to scale operations, expand partnerships, and grow the team.

Market Expansion: Company updates indicate launches beyond New York into states like Ohio and New Jersey, pointing to a widening geographic footprint. Public materials also highlight school partnerships and rising therapy-session volumes since launch, consistent with expansion.

Strong Hiring & Retention: Open roles across growth, operations, and product on company and third‑party job boards indicate active team growth. Leadership posts describe go‑to‑market hiring momentum ahead of school years, suggesting sustained scaling efforts.

Profitability: Recent reporting cites the company’s first annual profit, signaling improved financial stability after prior flat periods.

Strong Revenue Growth: Independent coverage notes a $125M–$130M annualized revenue run rate by late 2025 into 2026, indicating accelerated top-line momentum.

Market Expansion: Company updates and third-party reports describe expansion into additional states, active hiring, and plans to double the Seattle office footprint to support a larger team.

Market Expansion: Company disclosures indicate district coverage increased from more than 1,000 in 2021 to more than 1,900 by early 2026, implying multi‑year customer growth. Recent district documents referencing new or ongoing implementations in 2025–26 further support continued penetration.

Product Line Growth: In January 2026 the company launched Ellevation Benchmark, expanding into in‑year English language proficiency assessment and rounding out a unified ELD solution. Ongoing release notes and blog content highlight active investment and innovation across the platform.

Strategic Partnerships: Operating as a Curriculum Associates company since 2021 provides distribution strength and long‑term support that reinforce stability and scaling. State‑level initiatives and large‑district rollouts cited in public materials align with deeper market access.

Market Expansion: Public materials describe broadened operations across major U.S. hubs and international cities, with additional California expansion plans noted in March 2026 coverage. Company channels also reference global pickup coverage across North America, EMEA, and APJ.

Product Line Growth: Recent updates highlight expanded Device Retrievals and a unified, enterprise‑grade lifecycle platform. These feature additions indicate ongoing investment to address a wider range of assets and workflows.

Strong Hiring & Retention: Active recruitment for senior go‑to‑market roles and an updated headcount listing (e.g., 120 employees on Built In in June 2026) signal team expansion. Job descriptions and public posts depict a profitable, rapidly growing business consistent with scaling talent needs.

Profitability: Company filings indicate Udemy delivered its first full year of positive net income in 2025 alongside higher gross margin and expanded adjusted EBITDA. This points to improved operating discipline as the business shifts toward subscriptions and enterprise.

Future-Ready Strategy: Management accelerated a subscription‑first pivot on the Consumer side to favor durable, recurring revenue even at the expense of near‑term growth. Disclosures also emphasize AI‑driven features and hands‑on formats to align content with fast‑growing skills demand.

Strategic Partnerships: Udemy completed its merger with Coursera on May 11, 2026, positioning growth to be evaluated at a larger combined scale. The company also highlighted ecosystem partnerships intended to broaden formats, distribution, and monetization.

Investor Backing & Capital Strength: A March 3, 2026 investment of approximately $250 million from TPG’s The Rise Funds signals strong capital support to scale Findhelp’s “connected safety net” platform. Deal materials describe the round as intended to accelerate growth, expand the national network, and fund technology investment.

Strong Market Position & Advantage: Consecutive Best in KLAS awards in the SDoH Networks category through 2026 and publicized category leadership indicate durable competitive positioning. Feedback suggests such third‑party validation aligns with customer growth and traction.

Market Expansion: Expanding integrations and partnerships (e.g., Epic, NextGen, athenahealth, eClinicalWorks; AIDA Healthcare) and recent public‑sector activity (e.g., TennCare amendment, Pennsylvania eHealth data‑sharing) point to continued footprint growth. Government renewals and statewide engagements suggest ongoing adoption across agencies and markets.